126 related articles for article (PubMed ID: 27936396)
1. GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes.
Barton JC; Chen WP; Emond MJ; Phatak PD; Subramaniam VN; Adams PC; Gurrin LC; Anderson GJ; Ramm GA; Powell LW; Allen KJ; Phillips JD; Parker CJ; McLaren GD; McLaren CE
Blood Cells Mol Dis; 2017 Mar; 63():15-20. PubMed ID: 27936396
[TBL] [Abstract][Full Text] [Related]
2. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
[TBL] [Abstract][Full Text] [Related]
3. GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
Levstik A; Stuart A; Adams PC
Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
[TBL] [Abstract][Full Text] [Related]
4. Increased frequency of GNPAT p.D519G in compound HFE p.C282Y/p.H63D heterozygotes with elevated serum ferritin levels.
Secondes ES; Wallace DF; Rishi G; McLaren GD; McLaren CE; Chen WP; Ramm LE; Powell LW; Ramm GA; Barton JC; Subramaniam VN
Blood Cells Mol Dis; 2020 Nov; 85():102463. PubMed ID: 32652459
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload.
McLaren CE; Emond MJ; Subramaniam VN; Phatak PD; Barton JC; Adams PC; Goh JB; McDonald CJ; Powell LW; Gurrin LC; Allen KJ; Nickerson DA; Louie T; Ramm GA; Anderson GJ; McLaren GD
Hepatology; 2015 Aug; 62(2):429-39. PubMed ID: 25605615
[TBL] [Abstract][Full Text] [Related]
6. The D519G Polymorphism of Glyceronephosphate O-Acyltransferase Is a Risk Factor for Familial Porphyria Cutanea Tarda.
Farrell CP; Overbey JR; Naik H; Nance D; McLaren GD; McLaren CE; Zhou L; Desnick RJ; Parker CJ; Phillips JD
PLoS One; 2016; 11(9):e0163322. PubMed ID: 27661980
[TBL] [Abstract][Full Text] [Related]
7. Gnpat does not play an essential role in systemic iron homeostasis in murine model.
An P; Wang J; Wang H; Jiang L; Wang J; Min J; Wang F
J Cell Mol Med; 2020 Apr; 24(7):4118-4126. PubMed ID: 32108988
[TBL] [Abstract][Full Text] [Related]
8. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
[TBL] [Abstract][Full Text] [Related]
9. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
Barton JC; Barton JC; Acton RT
BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
[TBL] [Abstract][Full Text] [Related]
10. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
11. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
[TBL] [Abstract][Full Text] [Related]
12. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.
Gordeuk VR; Reboussin DM; McLaren CE; Barton JC; Acton RT; McLaren GD; Harris EL; Reiss JA; Adams PC; Speechley M; Phatak PD; Sholinsky P; Eckfeldt JH; Chen WP; Passmore L; Dawkins FW
Am J Hematol; 2008 Aug; 83(8):618-26. PubMed ID: 18429050
[TBL] [Abstract][Full Text] [Related]
13. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
15. Phlebotomy-mobilized iron as a surrogate for liver iron content in hemochromatosis patients.
Phatak PD; Barton JC
Hematology; 2003 Dec; 8(6):429-32. PubMed ID: 14668040
[TBL] [Abstract][Full Text] [Related]
16. Ethnic and genetic factors of iron status in women of reproductive age.
Gordeuk VR; Brannon PM
Am J Clin Nutr; 2017 Dec; 106(Suppl 6):1594S-1599S. PubMed ID: 29070555
[No Abstract] [Full Text] [Related]
17. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
18. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
19. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
20. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
